Merge Technologies has released its next-generation MergePort, which integrates information from hospital and radiology information systems with diagnostic imaging technologies. MergePort acts as the interpreter between multiple HIS/RIS and PACS/imaging
Merge Technologies has released its next-generation MergePort, which integrates information from hospital and radiology information systems with diagnostic imaging technologies. MergePort acts as the interpreter between multiple HIS/RIS and PACS/imaging networks, or any other clinical system that utilizes HL7 communications. MergePort receives, converts, and dispatches HL7, DICOM, and custom-formatted messages, securely integrating healthcare applications, imaging modalities, PACS, image archives, and clinical repositories.
Emerging PET/CT Agent Shows Promise in Detecting PCa Recurrence in Patients with Low PSA Levels
February 13th 202518F-DCFPyL facilitated detection of recurrent prostate cancer in 51 percent of patients with PSA levels ranging between 0.2 to 0.5 ng/ml, according to new research presented at the American Society of Clinical Oncology Genitourinary Cancers (ASCO-GU) Symposium.
Emerging MRI Scoring System May Help Predict Recurrent and Metastatic Hepatocellular Carcinoma
February 12th 2025Preoperative use of the scoring system for gadoxetic acid-enhanced MRI demonstrated an average AUC of 85 percent and average specificity of 89 percent in external validation cohorts for pathologic features of hepatocellular carcinoma.
Key Chest CT Parameters for Body Composition May be Prognostic for Patients with Resectable NSCLC
February 11th 2025A high intermuscular adipose index has a 49 percent increased likelihood of being associated with lower overall survival in patients with resectable non-small cell lung cancer (NSCLC), according to new research.